Purchase Description.pdf

PDF 145 KB Posted

Attached to
Genotyping Kits Federal contract opportunity
Solicitation number
75N95022Q00203
Issued by
Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse

View the file

Other files for this federal contract opportunity

Other files attached to Genotyping Kits, newest first.
File Type Posted
Purchase Description Revised.pdf PDF
FAR_52.204-24_Oct_2020.pdf PDF
FAR 52.212-5 (May 2022)..pdf PDF
FAR 52.204-26_Oct_2020.pdf PDF

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

PURCHASE DESCRIPTION

1. Statement of Need and Purpose: The purpose of this acquisition is to provide supplies to the Center for Alzheimer’s Disease and Related Dementias (CARD) for neurodegenerative disease research for the purpose of genotyping DNA samples on Illumina manufactured sequencing systems. These reagents will be used to identify causative genes for neurodegenerative diseases.

2. Background Information and Objective: Automated robotic Illumina sequencing systems require the use of proprietary reagents to ensure efficient operation and the desired outcomes of the operating systems. lllumina has been used successfully by our lab on multiple occasions for genotyping analysis. CARD has purchased through competitive procedures a number of Illumina’s genotyping and sequencing systems which have proven platform for genetic analysis and functional genomics. Each of the Illumina systems requires the use of reagents and consumables to ensure efficient operation and the desired outcomes of the operating systems. Reagents are chemicals and enzymes used to perform an assay or research sequencing methodology. All reagents must be compatible with, and optimally perform in the Illumina manufactured systems. CARD uses standardized protocols with the Illumina equipment and there are additional protocols in process and at the development stage.

3. Generic Name of Product: Genotyping kits

4. Purchase Description:

Infinium Global Diversity Array-8+ v1.0 Kit (384 Samples), Product no: 20031816

Infinium Global Diversity Array-8+ v1.0 Kit (96 Samples), Product no: 20031815

Infinium Global Diversity Array-8+ v1.0 Kit (16 Samples), Product no: 20031813

5. Salient characteristics All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and Contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.

6. Quantity:

Infinium Global Diversity Array-8+ v1.0 Kit (384 Samples), Product no: 20031816

QTY: 37

Infinium Global Diversity Array-8+ v1.0 Kit (96 Samples), Product no: 20031815

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

QTY: 1

Infinium Global Diversity Array-8+ v1.0 Kit (16 Samples), Product no: 20031813

QTY: 2

Shipping Charge

7. Delivery Date: Delivery date of 2 months after receipt of completed purchase order

File details come from the government source that posted it. Updated .